Cargando…
Botulinum Toxin-A for the Treatment of Neuropathic Pain after Decompressive Craniotomy in Stroke: Two Cases
Botulinum toxin-A (BoNT-A) is recommended as third-line off-label treatment for the management of neuropathic pain. BoNT-A has been reported as treatment for different neuropathic pain conditions; however, not for neuropathic pain after decompressive craniotomy for stroke. The aim of this retrospect...
Autores principales: | Teuschl, Yvonne, Bancher, Christian, Dachenhausen, Alexandra, Matz, Karl, Pinter, Michaela M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601619/ https://www.ncbi.nlm.nih.gov/pubmed/37901125 http://dx.doi.org/10.1159/000532096 |
Ejemplares similares
-
COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study
por: Teuschl, Yvonne, et al.
Publicado: (2021) -
Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit
por: Teuschl, Yvonne, et al.
Publicado: (2018) -
Impact of COVID-19 related delays of botulinum toxin injections on the quality of life of patients with dystonia or spasticity
por: Teuschl, Yvonne, et al.
Publicado: (2021) -
Post-stroke pneumonia at the stroke unit – a registry based analysis of contributing and protective factors
por: Matz, Karl, et al.
Publicado: (2016) -
Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke
por: Matz, Karl, et al.
Publicado: (2020)